These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18464346)

  • 1. Medicare program; modification to the weighting methodology used to calculate the low-income benchmark amount. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Apr; 73(65):18176-82. PubMed ID: 18464346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Jan; 77(8):1877-83. PubMed ID: 22359793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulations regarding income-related monthly adjustment amounts to Medicare beneficiaries' prescription drug coverage premiums. Interim final rule with request for comments.
    Social Security Administration
    Fed Regist; 2010 Dec; 75(234):75884-96. PubMed ID: 21137594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulations regarding income-related monthly adjustment amounts to Medicare beneficiaries' prescription drug coverage premiums. Final rule.
    Social Security Administration
    Fed Regist; 2012 Jul; 77(143):43496-8. PubMed ID: 22834072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; special enrollment period and Medicare premium changes. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Jun; 73(125):36463-9. PubMed ID: 18677829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare program; policy and technical changes to the Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Apr; 73(73):20485-509. PubMed ID: 18464352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely?
    Jackson EA; Axelsen KJ
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP29-35. PubMed ID: 18991478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficiary price sensitivity in the Medicare prescription drug plan market.
    Frakt AB; Pizer SD
    Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; reduction in Medicare Part B premiums as additional benefits under Medicare+Choice plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Nov; 68(229):66721-3. PubMed ID: 14649655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2014 May; 79(100):29843-968. PubMed ID: 24855709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(53):13397-400. PubMed ID: 15786588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program; revisions to the Medicare Advantage and Part D prescription drug contract determinations, appeals, and intermediate sanctions processes. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Dec; 72(233):68699-741. PubMed ID: 18064773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.